PrescriptionDrugs.org

Omeprazole vs Esomeprazole

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Omeprazole (Prilosec) and esomeprazole (Nexium) are proton pump inhibitors (PPIs) used to treat gastroesophageal reflux disease (GERD), peptic ulcers, and conditions involving excess stomach acid [1]. Esomeprazole is the S-enantiomer of omeprazole — essentially half of the omeprazole molecule — and was developed by AstraZeneca as a successor to Prilosec before its patent expiration [2]. Both drugs irreversibly inhibit the hydrogen-potassium ATPase enzyme system (the proton pump) in gastric parietal cells, reducing acid secretion by up to 97% [1]. The key clinical question is whether the purified enantiomer offers meaningful advantages over the racemic mixture.

Omeprazole vs Esomeprazole: Side-by-side comparison

CategoryOmeprazoleEsomeprazole
Drug ClassProton Pump Inhibitor (racemic)Proton Pump Inhibitor (S-enantiomer)
FDA-Approved UsesGERD, Erosive Esophagitis, H. pylori, Zollinger-EllisonGERD, Erosive Esophagitis, H. pylori, Zollinger-Ellison, NSAID Ulcer Prevention
Typical Dose20 mg once daily20–40 mg once daily
OTC AvailableYes (Prilosec OTC)Yes (Nexium 24HR)
Generic Cost (30-day)$3–10$8–20
CYP2C19 InteractionStronger (FDA warning with clopidogrel)Weaker interaction
Erosive Esophagitis Healing (8 wk)~87% (20 mg)~94% (40 mg)
Common Side EffectsHeadache, diarrhea, nauseaHeadache, diarrhea, nausea

Efficacy: How well does each drug work?

Both omeprazole and esomeprazole provide potent acid suppression and heal erosive esophagitis at high rates (>90% at 8 weeks) [1]. Esomeprazole 40 mg has shown statistically superior healing rates compared to omeprazole 20 mg in large clinical trials, particularly for severe (Los Angeles grade C/D) erosive esophagitis — 94% vs 87% healing at 8 weeks [2]. However, when equivalent doses are compared (esomeprazole 20 mg vs omeprazole 20 mg), the differences are minimal and often not clinically significant [3]. Pharmacokinetic studies show esomeprazole achieves higher area under the curve (AUC) values, meaning greater total acid suppression over 24 hours [2]. For H. pylori eradication, both are equally effective as part of triple therapy. For symptom relief in non-erosive GERD, clinical trials show no meaningful difference between the two drugs [4].

Side effects comparison

As members of the same drug class, omeprazole and esomeprazole share nearly identical side-effect profiles. Common adverse effects include headache (3–7%), diarrhea (2–4%), nausea (2–3%), and abdominal pain (2–3%) [1]. Long-term PPI use (>1 year) carries class-wide concerns including increased risk of C. difficile infection, hypomagnesemia, vitamin B12 deficiency, and potential bone fracture risk (FDA safety communication) [3]. There is no evidence that one drug carries more long-term risk than the other. Both may interact with clopidogrel by inhibiting CYP2C19, though esomeprazole may have a slightly weaker interaction [2]. The FDA has issued a specific warning about the omeprazole-clopidogrel interaction and recommends considering alternative PPIs [4]. Both are generally well tolerated for short-term use (4–8 weeks).

Cost comparison

This is where the most significant difference emerges. Generic omeprazole 20 mg (30 capsules) is available for $3–10 at most pharmacies and is sold over-the-counter as Prilosec OTC [1]. Generic esomeprazole 20 mg (30 capsules) costs $8–20 as a prescription and is also available OTC as Nexium 24HR for $15–25. Brand-name Nexium prescription remains expensive at $250–350/month when available. Given the minimal clinical difference at equivalent doses, omeprazole offers substantially better value [3]. Both are covered by most insurance formularies, though some plans require prior authorization for esomeprazole due to cost.

Convenience and dosing

Both are taken once daily, 30–60 minutes before the first meal of the day for optimal acid suppression [1]. Omeprazole is available in 10, 20, and 40 mg capsules and a 2.5/10 mg oral suspension packet [2]. Esomeprazole comes in 20 and 40 mg capsules and a 2.5/5/10/20/40 mg packet for oral suspension. Both can be opened and mixed with applesauce for patients with swallowing difficulty. OTC availability makes both convenient to obtain without a prescription for short-term use (14-day courses). Neither requires renal dose adjustment. For hepatic impairment, dose reductions are recommended for both, but esomeprazole has clearer dosing guidelines for severe liver disease [2].

Which is right for you?

For most patients, omeprazole is the practical first choice due to its lower cost, equivalent efficacy at standard doses, and widespread OTC availability [1][3]. Esomeprazole may be preferred for patients with severe erosive esophagitis (LA grade C/D) who need maximum healing rates, those taking clopidogrel who need a PPI (slightly lower CYP2C19 interaction), or patients with severe hepatic impairment (clearer dosing data) [2]. The American Gastroenterological Association considers all PPIs therapeutically equivalent for most indications [4]. If one PPI does not adequately control symptoms, switching to another PPI (including between omeprazole and esomeprazole) is reasonable. Consult your healthcare provider for guidance on the best choice for your condition.

Frequently asked questions

References

  1. [Regulatory] FDA. Prilosec (omeprazole) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019810s096lbl.pdf Accessed 2026-03-01.
  2. [Regulatory] FDA. Nexium (esomeprazole magnesium) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021153s050lbl.pdf Accessed 2026-03-01.
  3. [Regulatory] Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ. 2008;336(7634):2-3. https://pubmed.ncbi.nlm.nih.gov/18174564/ Accessed 2026-03-01.
  4. [Regulatory] Freedberg DE, et al. The risks and benefits of long-term use of proton pump inhibitors. Gastroenterology. 2017;152(4):706-715. https://pubmed.ncbi.nlm.nih.gov/28257716/ Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: